methyllycaconitine has been researched along with 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, YJ; Chin-Sheng, H; Ho, YS; Kuo, LJ; Lien, YC; Lin, FY; Liu, HH; Wang, W; Wei, PL; Wu, CH | 1 |
1 other study(ies) available for methyllycaconitine and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Article | Year |
---|---|
NNK enhances cell migration through α7-nicotinic acetylcholine receptor accompanied by increased of fibronectin expression in gastric cancer.
Topics: Aconitine; Adenocarcinoma; alpha7 Nicotinic Acetylcholine Receptor; Carcinogens; Cell Line, Tumor; Cell Movement; Fibronectins; Genetic Vectors; Humans; Nitrosamines; Plasmids; Receptors, Nicotinic; RNA Interference; Stomach Neoplasms; Transfection; Up-Regulation | 2012 |